Larvol Delta - STENOVA-TRIAL-UPDATE-OPENLABEL-EXTENSION-OF-ONTUNISERTIB-IN-FIBROSTENOSING-CROHN39S-DISEASE-WITH-OBJECTIVE-IMAGING-EFFICACY-ASSESSMENTS

ontunisertib (AGMB-129) - AgomAb Therapeutics

https://programme.ueg.eu/2026/week/details/sessions/383

Florian Rieder

Jul 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next